These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 10874025)
1. APC truncation and increased beta-catenin levels in a human breast cancer cell line. Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025 [TBL] [Abstract][Full Text] [Related]
2. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146 [TBL] [Abstract][Full Text] [Related]
3. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552 [TBL] [Abstract][Full Text] [Related]
4. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898 [TBL] [Abstract][Full Text] [Related]
5. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484 [TBL] [Abstract][Full Text] [Related]
6. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics. Wakita K; Tetsu O; McCormick F Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Sparks AB; Morin PJ; Vogelstein B; Kinzler KW Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795 [TBL] [Abstract][Full Text] [Related]
8. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Jin Z; Tamura G; Tsuchiya T; Sakata K; Kashiwaba M; Osakabe M; Motoyama T Br J Cancer; 2001 Jul; 85(1):69-73. PubMed ID: 11437404 [TBL] [Abstract][Full Text] [Related]
9. Loss of beta-catenin expression in metastatic gastric cancer. Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245 [TBL] [Abstract][Full Text] [Related]
10. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related]
11. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Choi YW; Heath EI; Heitmiller R; Forastiere AA; Wu TT Mod Pathol; 2000 Oct; 13(10):1055-9. PubMed ID: 11048797 [TBL] [Abstract][Full Text] [Related]
12. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype. Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042 [TBL] [Abstract][Full Text] [Related]
13. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341 [TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491 [TBL] [Abstract][Full Text] [Related]
15. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Suriano G; Vrcelj N; Senz J; Ferreira P; Masoudi H; Cox K; Nabais S; Lopes C; Machado JC; Seruca R; Carneiro F; Huntsman DG Genes Chromosomes Cancer; 2005 Mar; 42(3):238-46. PubMed ID: 15609344 [TBL] [Abstract][Full Text] [Related]
16. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. Green DW; Roh H; Pippin JA; Drebin JA J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549 [TBL] [Abstract][Full Text] [Related]
17. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138 [TBL] [Abstract][Full Text] [Related]
18. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655 [TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748 [TBL] [Abstract][Full Text] [Related]
20. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas. Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]